Rizvi Syed Ali-aamir bought RCKT
October 6, 2025 · Form 4 insider transaction
Rizvi Syed Ali-aamir bought 283,018 shares of Rocket Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
283,018
Price
$0.00
Total value
N/A
InsiderRizvi Syed Ali-aamir
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 6, 2025
Filing dateOctober 8, 2025
Shares owned after283,018
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on October 6, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.